Smruthi Organics (BOM:540686) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Smruthi Organics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Smruthi Organics's Free Cash Flow for the three months ended in Mar. 2024 was ₹0 Mil. Smruthi Organics's Revenue for the three months ended in Mar. 2024 was ₹397 Mil. Therefore, Smruthi Organics's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Smruthi Organics's current FCF Yield % is -2.07%.

The historical rank and industry rank for Smruthi Organics's FCF Margin % or its related term are showing as below:

BOM:540686' s FCF Margin % Range Over the Past 10 Years
Min: -3.29 Med: 7.42 Max: 17.35
Current: -3.01

During the past 13 years, the highest FCF Margin % of Smruthi Organics was 17.35%. The lowest was -3.29%. And the median was 7.42%.

BOM:540686's FCF Margin % is ranked worse than
58.06% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 0.25 vs BOM:540686: -3.01

Smruthi Organics FCF Margin % Historical Data

The historical data trend for Smruthi Organics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smruthi Organics FCF Margin % Chart

Smruthi Organics Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

12.96

15.23

-3.29

1.87

-3.01

Smruthi Organics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Smruthi Organics's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Smruthi Organics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Smruthi Organics's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Smruthi Organics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Smruthi Organics's FCF Margin % falls into.

Smruthi Organics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Smruthi Organics's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	-38.359	/	1276.431
	=	-3.01 %

Smruthi Organics's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0	/	396.577
	=	0.00 %

Smruthi Organics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Smruthi Organics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Smruthi Organics (BOM:540686) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Smruthi Organics Ltd (BOM:540686) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

165-A, Balaji Bhavan, 1st Floor, Railway Lines, Solapur, MH, IND, 413 001

Website

https://www.smruthiorganics.com

Smruthi Organics Ltd is engaged in the manufacture of bulk drugs and drug intermediates (API Products). The product portfolio includes Amlodipine Besilate, Amlodipine Base, S-Amlodipine Besilate, S-Amlodipine Base, Norfloxacin, Metformin HCI, Diloxanide Furoate, Phthaloyl Amlodipine, Pantoprazole Sodium, Pefloxacin Mesylate Dihydrate, Telmisartan, Losartan Potassium and many more. It has two segments Bulk Drugs and Drugs Intermediates (API) and Formulation. it generates the majority of its revenue from the Bulk Drugs and Drugs Intermediates (API) segment.

Smruthi Organics (BOM:540686) Headlines

No Headlines